Trial Information

Summary: Research study of an investigational medication compared to placebo (an inactive substance) for the treatment of Generalized Anxiety Disorder.

A phase 3, randomized, double-blind, placebo-controlled, parallel group, 12-week trial to assess the efficacy and safety of PD 0332334 for the treatment of Generalized Anxiety Disorder.

Length of study: 12 weeks

Number of office visits: 9 for most subjects

At no cost, qualified participants receive study medication and study related services. In addition there is compensation of $75 per completed visit (up to $675.00) for participation in the study.

This study is only available to persons who:

  • Can fluently read and speak English
  • Are 18 to 65 years old
  • Are without serious health problems
  • Do not have certain conditions such as Major Depressive or Obsessive-Compulsive Disorder
  • Are not addicted to drugs or alcohol
  • Are not currently receiving psychotherapy

Contact:

California Neuroscience Research Medical Group, Inc.
4835 Van Nuys Blvd. Suite 104
Sherman Oaks, CA 91403
Telephone: 818-990-2671
Email:

Profile Page: California Neuroscience Research Medical Group, Inc., Sherman Oaks, CA

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 19, 2008 at 2:42:55 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA